Teicoplanin

Research use only, not for human use.

Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria.

Teicoplanin is a semisynthetic glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.

——

Animal Model:20-30 g, Male CD1 mice (2?*?106 cfu/mL MRSA (43?300) 50 μL; murine thigh infection model)Dosage:10, 30 mg/kg Administration:I.v.; once every 12?h Result:Showed a dose-dependent decline in the total bacterial density with the total bactericidal effect was achieved with dosages of ≥10?mg/kg/day and suppression of resistance with dosages ≥30?mg/kg/day.

Antibiotic 8327A | Antibiotic MDL 507 | MDL 507

Others

Other Targets

Others

Infection

——

61036-62-2

1709.39

C77H77N5O31CI2R

>98% (HPLC)

Water: 100 mg/mL (58.5 mM)

CCCCCCCCC/C(O)=N/[C@]([C@@](OC1=C2C=C([C@](/N=C(O)\[C@](/N=C(O)/[C@@](/N=C(O)\[C@@](N)([H])C3=CC4=C(O)C=C3)([H])CC5=CC(Cl)=C(O2)C=C5)([H])C6=CC(O)=CC(O4)=C6)([H])/C(O)=N/[C@](/C(O)=N/7)([H])C8=CC(C9=C([C@@]%10([H])C(O)=O)C=C(O)C=C9OC%11([H])[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O%11)([H])CO)=C(O)C=C8)C=C1OC%12=C(Cl)C=C([C@](O[C@@]%13([H])[C@@](/N=C(O)/C)([H])[C@](O)([H])[C@@](O)([H])[C@@](O%13)([H])CO)([H])[C@@]7([H])/C(O)=N/%10)C=C%12)([H])O%14)([H])[C@](O)([H])[C@@](O)([H])[C@@]%14([H])CO

34-O-[2-(acetylamino)-2-deoxy-.beta.-D-glucopyranosyl]-22,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(8-methyl-1-oxononyl)amino]-.beta.-D-glucopyranosyl]-42-O-.alpha.-D-mannopyranosyl-

(-20℃)

With Ice Pack

≥ 2 years